Skip to content

Super Chinese Nephrotic Syndrome Registration System (SUCCESS)

Super Chinese Nephrotic Syndrome Registration System (SUCCESS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03001934
Enrollment
5000
Registered
2016-12-23
Start date
2016-04-01
Completion date
2029-12-01
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic Syndrome

Keywords

Nephrotic syndrome, Treatment response, Renal function

Brief summary

The investigators are registering all nephrotic syndrome (NS) patients regardless of the primary causes and developing a NS database in China. Patients will be followed-up and both baseline and follow-up information will be recorded in the registration system. The treatment response, longitudinal changes of renal function, renal survival, patient survival, infection events and acute kidney injury etc, will be analyzed using the NS database.

Detailed description

The investigators are registering all NS patients regardless of the primary causes in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education), clinical characteristics (including systolic blood pressure, diastolic blood pressure, primary cause of NS, and lab measurements of serum, urine), pathological characteristics, treatment and treatment response, complications and outcomes. Patients will be followed up, the demographic, clinical characteristics, treatment, lab tests of blood and urine and complications of patients will be collected and recorded at each visit. The investigators also record the outcome at each visit, such as treatment response, longitudinal changes of renal function, hospitalization, occurrence of infection or cardiovascular events etc. The outcomes will be analyzed using the NS database.

Interventions

OTHERNo intervention

Registration of all NS patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals which have signed the contract in China.

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Nephrotic syndrome patients regardless of the primary causes

Exclusion criteria

* No

Design outcomes

Primary

MeasureTime frame
The patient survival in NS patients10 years

Secondary

MeasureTime frameDescription
Renal survival in NS patients10 yearsRenal survival including end stage renal disease, dialysis, renal transplantation
Longitudinal changes of renal function of NS patients10 years
Treatment response of NS patients10 years
Infection rate of NS patients10 years

Countries

China

Contacts

CONTACTXueqing Yu, M.D. & Ph.D
yuxq@mail.sysu.edu.cn
CONTACTNaya Huang, M.D. & Ph.D
huangnaya@163.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026